Device Trial Radar · NCT07764146
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease
Last checked: Nov 19, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
18
Planned (sponsor's estimate)
Start
Sep 3, 2026
Primary completion
Apr 28, 2029
Study completion Apr 28, 2029
Sponsor
- Lead sponsor
- Voyager TherapeuticsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 13, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 30 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
VY1706 first in human study in early Alzheimer's Disease is a multicenter dose escalation study
Conditions
- Alzheimer s Disease
Interventions
VY1706 Low doseDrug
Low dose
VY1706 Mid doseDrug
Mid Dose
VY1706 High DoseDrug
High dose
Anti-AAV9 Total Antibody (TAb) AssayDevice
Anti-AAV9 Total Antibody (TAb) Assay
Primary outcomes
What the sponsor says the trial is designed to measure.
- To characterize the safety and tolerability in participants with AD by Incidence of treatment emergent adverse events, changes from baseline in vital signs, physical and neurological exams and other safety measuresTime frame: 52 weeks
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
K2 Medical Research, LLC
Maitland, Florida · Recruiting
AdventHealth Orlando
Orlando, Florida · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.